XenoTherapeutics to acquire Repare Therapeutics in all-cash deal
CAMBRIDGE — Repare Therapeutics Inc (RPTX.O), a clinical-stage precision oncology firm, said on Saturday it has agreed to be acquired by nonprofit biotech XenoTherapeutics Inc and its affiliate Xeno Acquisition Corp in an all-cash transaction that includes contingent value rights…